As FDA scrutinizes immunotherapy approvals, Merck says Keytruda extends survival in liver cancer trial
The FDA has been under pressure to review the status of drugs granted accelerated approvals based on early data, as in some cases confirmatory trials haven't been com...
Continue Reading →
